View in EDS HTML Full Text PDF Full Text

Growth hormone directly favors hepatic ketogenesis in persons with prediabetes or type 2 diabetes mellitus treated with empagliflozin.

Saved in:
Bibliographic Details
Title: Growth hormone directly favors hepatic ketogenesis in persons with prediabetes or type 2 diabetes mellitus treated with empagliflozin.
Authors: da Rocha AF; Post-graduation Program of Health Sciences, Londrina State University, Londrina, Brazil., Pereira Junior PS; Undergraduate Physiotherapy Course, Londrina State University, Londrina, Brazil., Calefi GS; Undergraduate Medicine Course, Londrina State University, Londrina, Brazil., Marquezine GF; Division of Endocrinology, Department of Internal Medicine, Londrina State University, Londrina, Brazil., Morimoto HK; Department of Pathology, Clinical and Toxicological Analysis, Health Sciences Center, Londrina State University, Londrina, Brazil., Mazzuco TL; Division of Endocrinology, Department of Internal Medicine, Londrina State University, Londrina, Brazil., de Faria EC; Lipids Laboratory, Department of Clinical Pathology, Faculty of Medical Sciences, State University of Campinas, Sao Paulo, Brazil., Urbano MR; Department of Statistics, Londrina State University, Londrina, Brazil., Carrilho AJF; Post-graduation Program of Health Sciences, Londrina State University, Londrina, Brazil. acarrilho@uel.br.; Division of Endocrinology, Department of Internal Medicine, Londrina State University, Londrina, Brazil. acarrilho@uel.br.
Source: Endocrine [Endocrine] 2021 Aug; Vol. 73 (2), pp. 325-330. Date of Electronic Publication: 2021 Apr 19.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9434444 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0100 (Electronic) Linking ISSN: 1355008X NLM ISO Abbreviation: Endocrine Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1559-0100
DOI:10.1007/s12020-021-02730-0